Larsen, Emil List; Nilius, Henning; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian; Wuillemin, Walter A; Gerber, Bernhard; Vishnu, Prakash; Graf, Lukas; Kremer Hovinga, Johanna A; Goetze, Jens P; Bakchoul, Tamam; Nagler, Michael (2024). Accuracy of Diagnosing Heparin-Induced Thrombocytopenia. JAMA Network Open, 7(3) American Medical Association 10.1001/jamanetworkopen.2024.3786
|
Text
larsen_2024_oi_240165_1710778707.79012.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
IMPORTANCE
Heparin-induced thrombocytopenia (HIT) is a life-threatening condition that requires urgent diagnostic clarification. However, knowledge of the diagnostic utility of the recommended diagnostic tests is limited in clinical practice.
OBJECTIVE
To evaluate the current diagnostic practice for managing the suspicion of HIT.
DESIGN, SETTING, AND PARTICIPANTS
This prospective diagnostic study was conducted from January 2018 to May 2021 among consecutive patients with suspected HIT from 11 study centers in Switzerland, Germany, and the United States. Detailed clinical data and laboratory information were recorded. Platelet factor 4/heparin antibodies were quantified using an automated chemiluminescent immunoassay (CLIA). A washed-platelet heparin-induced platelet activation (HIPA) test was used as a reference standard to define HIT.
EXPOSURES
Suspicion of HIT.
MAIN OUTCOMES AND MEASURES
The primary outcome was the diagnostic accuracy of the 4Ts score, the CLIA, and the recommended algorithm serially combining both tests.
RESULTS
Of 1448 patients included between 2018 and 2021, 1318 were available for the current analysis (median [IQR] age, 67 [57-75] years; 849 [64.6%] male). HIPA was positive in 111 patients (prevalence, 8.4%). The most frequent setting was intensive care unit (487 [37.0%]) or cardiovascular surgery (434 [33.0%]). The 4Ts score was low risk in 625 patients (46.8%). By 2 × 2 table, the numbers of patients with false-negative results were 10 (9.0%; 4Ts score), 5 (4.5%; CLIA), and 15 (13.5%; recommended diagnostic algorithm). The numbers of patients with false-positive results were 592 (49.0%; 4Ts score), 73 (6.0%; CLIA), and 50 (4.1%; recommended diagnostic algorithm), respectively.
CONCLUSIONS AND RELEVANCE
In this diagnostic study of patients suspected of having HIT, when the recommended diagnostic algorithm was used in clinical practice, antibody testing was required in half the patients. A substantial number of patients were, however, still misclassified, which could lead to delayed diagnosis or overtreatment. Development of improved diagnostic algorithms for HIT diagnosis should be pursued.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
Graduate School: |
Graduate School for Health Sciences (GHS) |
UniBE Contributor: |
Nilius, Henning Jürgen Jean, Kremer Hovinga Strebel, Johanna Anna |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2574-3805 |
Publisher: |
American Medical Association |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
27 Mar 2024 08:48 |
Last Modified: |
28 Mar 2024 03:51 |
Publisher DOI: |
10.1001/jamanetworkopen.2024.3786 |
PubMed ID: |
38530310 |
BORIS DOI: |
10.48350/194892 |
URI: |
https://boris.unibe.ch/id/eprint/194892 |